Article
Criterios de selección y factores pronósticos para la cirugía citorreductora (CRS) más quimioterapia intraperitoneal hipertérmica (HIPEC) en el cáncer gástrico con metástasis peritoneales: una revisión sistemática
2026-06-16
Abstract excerpt
Peritoneal dissemination of gastric adenocarcinoma imposes a phenotype highly resistant to conventional systemic regimens. Following the PRISMA 2020 guidelines and the PROSPERO protocol (CRD420261412861), a critical review was conducted to elucidate eligibility criteria and prognostic determinants in adults undergoing cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). The...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 537f6368-bf90-57a6-8f6e-f0e88c8a27b8
- DOI
- 10.1590/scielopreprints.16443
